General note | In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP). |
General note | GPO Cataloging Record Distribution Program (CRDP). |
Bibliography note | Includes bibliographical references. |
Performer |
Hearing witnesses: Lawrence A. Tabak, D.D.S., Ph.D., Senior Official Performing the Duties of Director, National Institutes of Health; Answers to submitted questions \1\ Rochelle P. Walensky, M.D., Director, Centers for Disease Control and Prevention; Answers to submitted questions \1\ Robert M. Califf, M.D., Commissioner, Food and Drug Administration, Department of Health and Human Services. |
Date/time/place of a event note | Date of hearing: 2023-02-08. |
Source of description | Description based on online resource, PDF version; title from title page (GovInfo, viewed March 6, 2024). |
Issued in other form | Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. Federal response to COVID-19 |
Genre/form | Legislative hearings. |
Standard identifier# |
52-490 (GPO jacket number) |
GPO item number | 1019-C-01 (online) |
Govt. docs number |
Y 4.C 73/8:118-7 |